Dennis Podlesak is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 141,763 shares of SNDX, which is worth approximately $2.28 Million. The most recent transaction as insider was on Feb 07, 2024, when has been sold 34,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K
0% 3M change
31.55% 12M change
Total Value Held $2.28 Million

Dennis Podlesak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
BUY
Grant, award, or other acquisition
-
34,000 Added 19.34%
141,763 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
32,000 Added 22.9%
107,763 Common Stock
Sep 16 2022
SELL
Open market or private sale
$280,574 $23.43 p/Share
11,975 Reduced 13.65%
75,763 Common Stock
Sep 16 2022
BUY
Exercise of conversion of derivative security
$75,922 $6.34 p/Share
11,975 Added 12.7%
82,319 Common Stock
Sep 15 2022
SELL
Open market or private sale
$1,617,528 $24.2 p/Share
66,840 Reduced 46.87%
75,763 Common Stock
Sep 15 2022
BUY
Exercise of conversion of derivative security
$422,429 $6.32 p/Share
66,840 Added 31.91%
142,603 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
32,000 Added 29.69%
75,763 Common Stock
Oct 05 2021
BUY
Other acquisition or disposition
-
463 Added 1.05%
43,763 Common Stock
Apr 22 2021
BUY
Open market or private purchase
$197,074 $14.11 p/Share
13,967 Added 24.39%
43,300 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
29,333 Added 50.0%
29,333 Common Stock
DP

Dennis Podlesak

Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Track Activities on SNDX